ckd and semaglutide in patients with overweight or obesity chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial Frontiers | Influence of chronic

Local Common (1% to 10%): Injection site reactions (subcutaneous formulation) Injection site reactions included administration site reactions, application/instillation site reactions, erythema, induration, inflammation, infusion site reactions, injection site discomfort, injection site pruritus, injection site rash, and irritation

Patients with drastic changes in their facial appearance sometimes also opt for plastic surgery

Perl S, Schmolzer I, Sourij H, Pressl H, Eder M, Zweiker R, Wascher TC

In response, the General Pharmaceutical Council has issued fresh guidance to online pharmacies, informing them that they will now have to employ stricter checks to stop people who are already a healthy weight or have a history of eating disorders from buying weight-loss jabs